|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1211 |
Code Value |
Code Meaning |
Definition |
Notes |
112036 |
ACR Position Statement |
AmericanCollegeofRadiology.ACRPositionStatement |
|
|
|
for Quality Control and Improvement, Safety, Infection |
|
|
|
Control, and Patient Concerns. In: Practice Guidelines |
|
|
|
and Technical Standards. Reston, Va: 2001:iv. |
|
112037 |
Non-lesion Modifier |
A descriptor for a non-lesion object finding or feature, |
|
|
|
used to indicate whether the object was detected as |
|
|
|
being internal or external to the patient's body. |
|
112038 |
Osseous Modifier |
A concept modifier for an Osseous Anatomy, or bone |
|
|
|
related, finding. |
|
112039 |
Tracking Identifier |
A text label used for tracking a finding or feature, |
|
|
|
potentially across multiple reporting objects, over time. |
|
|
|
This label shall be unique within the domain in which it |
|
|
|
is used. Corresponds to Tracking ID (0062,0020). |
|
112040 |
Tracking Unique Identifier |
A unique identifier used for tracking a finding or feature, |
|
|
|
potentially across multiple reporting objects, over time. |
|
|
|
Corresponds to Tracking UID (0062,0021). |
|
112041 |
Target Lesion Complete |
Disappearance of all target lesions. |
|
|
Response |
|
|
112042 Target Lesion Partial ResponseAt least a 30% decrease in the sum of the Longest |
|
|
|
Diameter of target lesions, taking as reference the |
|
|
|
baseline sum Longest Diameter. |
|
112043 |
Target Lesion Progressive |
At least a 20% increase in the sum of the Longest |
|
|
Disease |
Diameter of target lesions, taking as reference the |
|
|
|
smallest sum Longest Diameter recorded since the |
|
|
|
treatmentstarted,ortheappearanceofoneormorenew |
|
|
|
lesions. |
|
112044 Target Lesion Stable Disease Neither sufficient shrinkage to qualify for Partial |
|
|
|
Response nor sufficient increase to qualify for |
|
|
|
Progressive Disease, taking as reference the smallest |
|
|
|
sum Longest Diameter since the treatment started. |
|
112045 |
Non-Target Lesion Complete |
Disappearanceofallnon-targetlesionsandnormalization |
|
|
Response |
of tumor marker level. |
|
112046 Non-Target Lesion IncompletePersistence of one or more non-target lesions and/or |
|
|
Response or Stable Disease |
maintenance of tumor marker level above the normal |
|
|
|
limits. |
|
112047 Non-Target Lesion ProgressiveAppearance of one or more new lesions and/or |
|
|
Disease |
unequivocal progression of existing non-target lesions. |
|
112048 |
Current Response |
The current response evaluation for treatment of solid |
|
|
|
tumors, according to a method such as RECIST. |
|
112049 |
Best Overall Response |
Best response recorded from the start of the treatment |
|
|
|
untildiseaseprogression/recurrence,takingasreference |
|
|
|
for Progressive Disease the smallest measurements |
|
|
|
recorded since the treatment started, according to a |
|
|
|
method such as RECIST. |
|
112050 |
Anatomic Identifier |
Atextidentifierofananatomicfeaturewhenamultiplicity |
|
|
|
of features of that type may be present, such as "Rib 1", |
|
|
|
"Rib 2" or thoracic vertebrae "T1" or "T2". |
|
112051 |
Measurement of Response |
A measured or calculated evaluation of response. E.g., |
|
|
|
accordingtoamethodsuchasRECIST,thevaluewould |
|
|
|
be the calculated sum of the lengths of the longest axes |
|
|
|
of a set of target lesions. |
|